A mutated version of the c-myc internal ribosomal entry site which is found prevalently in patients with multiple myeloma, is bound by hnRNP K more efficiently in vitro and c-myc is translated to a greater extent by hnRNP K in vivo (Evans et al, 2003). Here, HNRNPK is linked to plasma cell myeloma.